Presentation is loading. Please wait.

Presentation is loading. Please wait.

Epidemiologic overview of HIV/AIDS in Ontario and Toronto: 2004 update Robert S. Remis MD, MPH, FRCPC, Maraki Fikre Merid BSc Ontario HIV Epidemiologic.

Published byTobias Rogers Modified over 9 years ago

Similar presentations

Presentation on theme: "Epidemiologic overview of HIV/AIDS in Ontario and Toronto: 2004 update Robert S. Remis MD, MPH, FRCPC, Maraki Fikre Merid BSc Ontario HIV Epidemiologic."— Presentation transcript:

1 Epidemiologic overview of HIV/AIDS in Ontario and Toronto: 2004 update Robert S. Remis MD, MPH, FRCPC, Maraki Fikre Merid BSc Ontario HIV Epidemiologic Monitoring Unit Department of Public Health Sciences, University of Toronto Current HIV/AIDS Trends in Toronto Toronto Public Health Toronto, January 6, 2005

2 instructional media centre, Laboratories Branch - 2000 Background The HIV epidemic in Ontario, including Toronto, is unstable and dynamic The HIV epidemic in Ontario, including Toronto, is unstable and dynamic Critical to monitor trends in HIV transmission (incidence) and burden of HIV infection (prevalence) to evaluate effectiveness of prevention and assess the need for health and support services Critical to monitor trends in HIV transmission (incidence) and burden of HIV infection (prevalence) to evaluate effectiveness of prevention and assess the need for health and support services Dr. Robert S. Remis Public Health Sciences, University of Toronto

3 instructional media centre, Laboratories Branch - 2000 Organization of presentation Brief review of Ontario and Toronto HIV data Brief review of Ontario and Toronto HIV data Ontario HIV model 2003 Ontario HIV model 2003 Focus on evolving situations with respect to: Focus on evolving situations with respect to: MSM MSM IDU IDU HIV-endemic HIV-endemic Other heterosexual Other heterosexual Dr. Robert S. Remis Public Health Sciences, University of Toronto

4 instructional media centre, Laboratories Branch - 2000 Number of first-time HIV diagnoses by sex and proportion female, 1985–2003 Dr. Robert S. Remis Public Health Sciences, University of Toronto

5 instructional media centre, Laboratories Branch - 2000 First-time HIV-positive diagnoses among males (n=21,325), Ontario, 1985–2003 Dr. Robert S. Remis Public Health Sciences, University of Toronto

6 instructional media centre, Laboratories Branch - 2000 First-time HIV-positive diagnoses among females (n=3,409), Ontario, 1985–2003 Dr. Robert S. Remis Public Health Sciences, University of Toronto

7 instructional media centre, Laboratories Branch - 2000 Number of first-time HIV diagnoses MSM, Toronto, 1999–2004

8 instructional media centre, Laboratories Branch - 2000 Number of first-time HIV diagnoses for selected exposure categories, Toronto, 1999–2004

9 instructional media centre, Laboratories Branch - 2000 HIV incidence from detuned assay among MSM, Ontario, October 1999 – December 2003 Source: Laboratory Enhancement Study

10 instructional media centre, Laboratories Branch - 2000 HIV incidence from detuned assay among MSM, Toronto, October 1999 – December 2003 Source: Laboratory Enhancement Study

11 instructional media centre, Laboratories Branch - 2000 HIV incidence from detuned assay among MSM, Ottawa, October 1999 – December 2003 Source: Laboratory Enhancement Study

12 instructional media centre, Laboratories Branch - 2000 HIV incidence from detuned assay among MSM, other regions, October 1999 – December 2003 Source: Laboratory Enhancement Study

13 instructional media centre, Laboratories Branch - 2000 HIV incidence from detuned assay among IDU, Ontario, October 1999 – December 2003 Source: Laboratory Enhancement Study

14 instructional media centre, Laboratories Branch - 2000 HIV incidence from detuned assay among IDU, Toronto, October 1999 – December 2003 Source: Laboratory Enhancement Study

15 instructional media centre, Laboratories Branch - 2000 HIV incidence from detuned assay among IDU, Ottawa, October 1999 – December 2003 Source: Laboratory Enhancement Study

16 instructional media centre, Laboratories Branch - 2000 HIV incidence from detuned assay among IDU, other regions, October 1999 – December 2003 Source: Laboratory Enhancement Study

17 instructional media centre, Laboratories Branch - 2000 Modeled HIV prevalence and diagnoses by exposure category, Ontario, 2003 Dr. Robert S. Remis Public Health Sciences, University of Toronto

18 instructional media centre, Laboratories Branch - 2000 Modeled HIV infections by exposure category and health region, both sexes, Ontario, 2003 Dr. Robert S. Remis Public Health Sciences, University of Toronto

19 instructional media centre, Laboratories Branch - 2000 Modeled HIV infections by exposure category and health region, males, Ontario, 2003 Dr. Robert S. Remis Public Health Sciences, University of Toronto

20 instructional media centre, Laboratories Branch - 2000 Modeled HIV infections by exposure category and health region, females, Ontario, 2003 Dr. Robert S. Remis Public Health Sciences, University of Toronto

21 instructional media centre, Laboratories Branch - 2000 Modeled HIV prevalence among MSM Ontario, 1977–2003 Dr. Robert S. Remis Public Health Sciences, University of Toronto

22 instructional media centre, Laboratories Branch - 2000 MSM: Epidemiologic overview 14,370 HIV-infected (61% of Ontario infections), 69% diagnosed 14,370 HIV-infected (61% of Ontario infections), 69% diagnosed New HIV diagnoses 2004 up 54% over 2001, especially in Toronto and Central West regions New HIV diagnoses 2004 up 54% over 2001, especially in Toronto and Central West regions HIV prevalence 15% (Toronto 19%, Ottawa 18%, other 8%) HIV prevalence 15% (Toronto 19%, Ottawa 18%, other 8%) 1998-2003 prevalence up 29% (annual 5%) 1998-2003 prevalence up 29% (annual 5%) 690 new infections in 2003 690 new infections in 2003 HIV incidence 0.9% (Toronto 1.1%, Ottawa 1.5%, other 0.3%) HIV incidence 0.9% (Toronto 1.1%, Ottawa 1.5%, other 0.3%) Dr. Robert S. Remis Public Health Sciences, University of Toronto

23 instructional media centre, Laboratories Branch - 2000 Modeled HIV prevalence among IDUs Ontario, 1977–2003 Dr. Robert S. Remis Public Health Sciences, University of Toronto

24 instructional media centre, Laboratories Branch - 2000 IDU: Epidemiologic overview 1,960 HIV-infected (8% of Ontario infections), 67% diagnosed 1,960 HIV-infected (8% of Ontario infections), 67% diagnosed New HIV diagnoses stable overall past five years, though increase in 2004 in Southwest and Northern regions New HIV diagnoses stable overall past five years, though increase in 2004 in Southwest and Northern regions HIV prevalence 5% (Ottawa 15%, elsewhere 4%) HIV prevalence 5% (Ottawa 15%, elsewhere 4%) 1998-2003 prevalence up 8% (annual 1.5%) 1998-2003 prevalence up 8% (annual 1.5%) 80 new infections in 2003; HIV incidence 0.2% 80 new infections in 2003; HIV incidence 0.2% Relatively reassuring Relatively reassuring Dr. Robert S. Remis Public Health Sciences, University of Toronto

25 instructional media centre, Laboratories Branch - 2000 Modeled HIV prevalence persons from HIV-endemic regions, Ontario, 1977–2003 Dr. Robert S. Remis Public Health Sciences, University of Toronto

26 instructional media centre, Laboratories Branch - 2000 HIV-endemic: Epidemiologic overview 3,310 HIV-infected (13% of Ontario infections); 48% diagnosed 3,310 HIV-infected (13% of Ontario infections); 48% diagnosed HIV prevalence 0.8% HIV prevalence 0.8% Most HIV-infected persons in Toronto (75%) and Ottawa (15%) Most HIV-infected persons in Toronto (75%) and Ottawa (15%) 1998-2003 prevalence up 86% (annual 13%) 1998-2003 prevalence up 86% (annual 13%) New HIV diagnoses increased 1999 (160) to 2002 (280) then decreased somewhat (230 in 2004) New HIV diagnoses increased 1999 (160) to 2002 (280) then decreased somewhat (230 in 2004) 330 new HIV infections in 2003 (imported & Canada) 330 new HIV infections in 2003 (imported & Canada) Dr. Robert S. Remis Public Health Sciences, University of Toronto

27 instructional media centre, Laboratories Branch - 2000 Modeled HIV prevalence other persons infected heterosexually, Ontario, 1977–2003 Dr. Robert S. Remis Public Health Sciences, University of Toronto

28 instructional media centre, Laboratories Branch - 2000 Heterosexual : Epidemiologic overview 3,310 HIV-infected (14% of Ontario infections), 48% diagnosed 3,310 HIV-infected (14% of Ontario infections), 48% diagnosed 1998-2003 HIV prevalence up 64% (annual 10%) 1998-2003 HIV prevalence up 64% (annual 10%) 2000 to 2004, HIV diagnoses increased 70%; increased in most regions but especially Central West (+202%), Southwest (+160%) and Toronto (+74%) 2000 to 2004, HIV diagnoses increased 70%; increased in most regions but especially Central West (+202%), Southwest (+160%) and Toronto (+74%) 320 new HIV infections in 2003 320 new HIV infections in 2003 Dr. Robert S. Remis Public Health Sciences, University of Toronto

29 instructional media centre, Laboratories Branch - 2000 Summary of findings, Toronto MSM: still most important group; though HIV incidence from detuned assay appeared stable, HIV diagnoses increased 58% since 2001 MSM: still most important group; though HIV incidence from detuned assay appeared stable, HIV diagnoses increased 58% since 2001 IDU: stable HIV prevalence, low HIV incidence IDU: stable HIV prevalence, low HIV incidence HIV-endemic: now 2nd most important group, 13% of infected persons HIV-endemic: now 2nd most important group, 13% of infected persons Heterosexual: fastest growing group by far; ~69% increase in prevalence 1998-2003 (five years) Heterosexual: fastest growing group by far; ~69% increase in prevalence 1998-2003 (five years) Dr. Robert S. Remis Public Health Sciences, University of Toronto

30 instructional media centre, Laboratories Branch - 2000 Limitations Populations at risk not well characterized Populations at risk not well characterized Adjustments for HIV diagnoses, AIDS cases and HIV-related mortality subject to uncertainty Adjustments for HIV diagnoses, AIDS cases and HIV-related mortality subject to uncertainty Data on HIV incidence limited and biased Data on HIV incidence limited and biased Despite challenges, triangulation allows obtaining plausible estimates for HIV incidence and prevalence Despite challenges, triangulation allows obtaining plausible estimates for HIV incidence and prevalence Dr. Robert S. Remis Public Health Sciences, University of Toronto

31 instructional media centre, Laboratories Branch - 2000 Conclusions Good news: AIDS incidence and mortality decreasing and situation reassuring among IDUs Good news: AIDS incidence and mortality decreasing and situation reassuring among IDUs Overall, HIV epidemic in Ontario unstable Overall, HIV epidemic in Ontario unstable HIV prevalence up 36% past 5 years (17,400 to 23,600) HIV prevalence up 36% past 5 years (17,400 to 23,600) Concerning in MSM, HIV-endemic and heterosexual Concerning in MSM, HIV-endemic and heterosexual Sustained HIV transmission in these groups Sustained HIV transmission in these groups Dr. Robert S. Remis Public Health Sciences, University of Toronto

32 instructional media centre, Laboratories Branch - 2000 Acknowledgements Frank McGee, AIDS Bureau, Ontario Ministry of Health and Long Term Care (MOHLTC) Frank McGee, AIDS Bureau, Ontario Ministry of Health and Long Term Care (MOHLTC) Carol Swantee, HIV Laboratory, MOHLTC Carol Swantee, HIV Laboratory, MOHLTC Jane Njihia, FSO, PHAC / MOHLTC Jane Njihia, FSO, PHAC / MOHLTC Lorraine Schiedel, Public Health Branch, MOHLTC Lorraine Schiedel, Public Health Branch, MOHLTC Ontario HIV Treatment Network (OHTN) and Health Canada for funding Laboratory Enhancement Study Ontario HIV Treatment Network (OHTN) and Health Canada for funding Laboratory Enhancement Study

Download ppt "Epidemiologic overview of HIV/AIDS in Ontario and Toronto: 2004 update Robert S. Remis MD, MPH, FRCPC, Maraki Fikre Merid BSc Ontario HIV Epidemiologic."

Similar presentations

Satellite meeting on the STARHS HIV diagnostic assay in association with the 15th International AIDS Conference July 2004, Bangkok, Thailand Robert S.

Satellite meeting on the STARHS HIV diagnostic assay in association with the 15th International AIDS Conference July 2004, Bangkok, Thailand Robert S.
1 Data for 2012 Priority Setting in Small Doses #1 HIV/AIDS Surveillance Data.

1 Data for 2012 Priority Setting in Small Doses #1 HIV/AIDS Surveillance Data.
Estimating the number of Kentuckians living with HIV disease with unmet needs for HIV-related primary care in calendar year 2010  Reducing new HIV infections.

Estimating the number of Kentuckians living with HIV disease with unmet needs for HIV-related primary care in calendar year 2010  Reducing new HIV infections.
HIV and STD in Maine Data from the Bureau of Health HIV/STD Program Contact: Mark Griswold (207) 287-5193

HIV and STD in Maine Data from the Bureau of Health HIV/STD Program Contact: Mark Griswold (207)
STD Screening in HIV Clinics: Value and Implications Thomas Farley, MD MPH Tulane University Deborah Cohen, MD MPH RAND Corporation.

STD Screening in HIV Clinics: Value and Implications Thomas Farley, MD MPH Tulane University Deborah Cohen, MD MPH RAND Corporation.
HIV Infection in Michigan January 1, 2012 Michigan Department of Community Health HIV/STD/VH/TB Epidemiology Section Division of Communicable Diseases.

HIV Infection in Michigan January 1, 2012 Michigan Department of Community Health HIV/STD/VH/TB Epidemiology Section Division of Communicable Diseases.
HIV/AIDS Prevalence & Mortality Report, 2001 Minnesota Department of Health HIV/AIDS Surveillance System Minnesota Department of Health HIV/AIDS Surveillance.

HIV/AIDS Prevalence & Mortality Report, 2001 Minnesota Department of Health HIV/AIDS Surveillance System Minnesota Department of Health HIV/AIDS Surveillance.
HIV/AIDS Prevention Committee Public Meeting November 21, 2013.

HIV/AIDS Prevention Committee Public Meeting November 21, 2013.
Laboratories Branch, MOHLTC, IMC – 2001 The epidemiology of HIV infection among persons from HIV-endemic countries in Ontario Robert S. Remis MD Department.

Laboratories Branch, MOHLTC, IMC – 2001 The epidemiology of HIV infection among persons from HIV-endemic countries in Ontario Robert S. Remis MD Department.
Laboratories Branch, MOHLTC, IMC – 2001 The epidemiology of HIV infection among persons from HIV-endemic countries in Ontario: Update to 2002 Robert S.

Laboratories Branch, MOHLTC, IMC – 2001 The epidemiology of HIV infection among persons from HIV-endemic countries in Ontario: Update to 2002 Robert S.
Incorporating HIV and Viral Hepatitis Testing and Referral into Idaho Drug Court Programs Presented by Idaho Advisory Council on HIV and AIDS, Bebe Thompson,

Incorporating HIV and Viral Hepatitis Testing and Referral into Idaho Drug Court Programs Presented by Idaho Advisory Council on HIV and AIDS, Bebe Thompson,
1 HIV/STD Trends in Texas Sharon K. Melville, M.D., M.P.H. Texas Department of State Health Services Texas Public Health Association April 22, 2010.

1 HIV/STD Trends in Texas Sharon K. Melville, M.D., M.P.H. Texas Department of State Health Services Texas Public Health Association April 22, 2010.
2012 HIV/AIDS surveillance in Europe European Centre for Disease Prevention and Control, Stockholm WHO Regional Office for Europe, Copenhagen.

2012 HIV/AIDS surveillance in Europe European Centre for Disease Prevention and Control, Stockholm WHO Regional Office for Europe, Copenhagen.
Emerging Trends of HIV/AIDS in New York City Chris Williams, MPH NYC DOHMH.

Emerging Trends of HIV/AIDS in New York City Chris Williams, MPH NYC DOHMH.
Routine HIV Screening in Health Care Settings David Spach, MD Clinical Director Northwest AIDS Education and Training Center Professor of Medicine, Division.

Routine HIV Screening in Health Care Settings David Spach, MD Clinical Director Northwest AIDS Education and Training Center Professor of Medicine, Division.
HIV/AIDS in Michigan January 1, 2010 Michigan Department of Community Health HIV/STD/VH/TB Epidemiology Section Division of Communicable Diseases Bureau.

HIV/AIDS in Michigan January 1, 2010 Michigan Department of Community Health HIV/STD/VH/TB Epidemiology Section Division of Communicable Diseases Bureau.
1 AIDS 2010 Vienna, July 2010 HIV/AIDS and People from Countries where HIV is endemic – Black people of African and Caribbean descent living in Canada.

1 AIDS 2010 Vienna, July 2010 HIV/AIDS and People from Countries where HIV is endemic – Black people of African and Caribbean descent living in Canada.
HIV/STD Epidemiology in Oklahoma HIV/STD Service Division of Prevention and Preparedness Oklahoma State Department of Health.

HIV/STD Epidemiology in Oklahoma HIV/STD Service Division of Prevention and Preparedness Oklahoma State Department of Health.
Trends in high-risk sexual behaviour among homosexual men participating in the AIDSVAX ® B/B vaccine trial in Canada: Results to 12 months Robert S. Remis,

Trends in high-risk sexual behaviour among homosexual men participating in the AIDSVAX ® B/B vaccine trial in Canada: Results to 12 months Robert S. Remis,
Overview of the State of the HIV Epidemic in Canada Regional Session on USA and Canada XIX International AIDS Conference Howard Njoo MD, MHSc, FRCPC Director-General.

Overview of the State of the HIV Epidemic in Canada Regional Session on USA and Canada XIX International AIDS Conference Howard Njoo MD, MHSc, FRCPC Director-General.

Similar presentations

Ads by Google